Emany Sravan Kumar bought KYTX
February 24, 2026 · Form 4 insider transaction
Emany Sravan Kumar bought 11,006 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,006
Price
$0.00
Total value
N/A
InsiderEmany Sravan Kumar
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after11,006
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.